Perceptive Advisors’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-12,558
Closed -$5.91M 120
2018
Q2
$5.91M Sell
12,558
-27,161
-68% -$14.4M 0.15% 70
2018
Q1
$23.4M Sell
39,719
-5,000
-11% -$3.1M 0.66% 38
2017
Q4
$24.3M Buy
44,719
+7,900
+21% +$3.58M 0.8% 31
2017
Q3
$15.4M Hold
36,819
0.59% 42
2017
Q2
$9.12M Sell
36,819
-18,544
-33% -$5.22M 0.46% 50
2017
Q1
$16.9M Sell
55,363
-4,167
-7% -$1.02M 0.96% 33
2016
Q4
$8.68M Sell
59,530
-5,276
-8% -$785K 0.62% 40
2016
Q3
$5.61M Sell
64,806
-1,444
-2% -$112K 0.36% 63
2016
Q2
$4.41M Hold
66,250
0.31% 64
2016
Q1
$3.99M Hold
66,250
0.35% 64
2015
Q4
$5.97M Hold
66,250
0.44% 48
2015
Q3
$7.6M Buy
66,250
+842
+1% +$148K 0.61% 41
2015
Q2
$15.1M Buy
65,408
+29,991
+85% +$5.79M 0.91% 30
2015
Q1
$5.63M Buy
+35,417
New +$4.79M 0.44% 47

Other funds holding ASMB

Perceptive Advisors's ASMB Position: Q3 2018 in Review

Perceptive Advisors sold out of Assembly Biosciences (ASMB) in Q3 2018, closing a stake of 12,558 shares — an estimated $5.91M sold.

Perceptive Advisors first reported a position in ASMB in Q1 2015 and held it in 14 quarters. The position peaked at $24.3M in Q4 2017. 113 funds tracked by Wall St. Rank hold ASMB as of Q3 2018.

  • Perceptive Advisors reported no remaining Assembly Biosciences position as of Q3 2018 after selling out during the quarter.
  • Perceptive Advisors sold 12,558 Assembly Biosciences shares in Q3 2018, an estimated $5.91M.
  • Perceptive Advisors first reported a position in Assembly Biosciences in Q1 2015 and held it in 14 quarters.
  • Perceptive Advisors's Assembly Biosciences position peaked at $24.3M in Q4 2017.
  • 113 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2018.

Based on Perceptive Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.